Predicting complications after ERCP procedures
Machine Learning for the Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Complication Risk
The First Affiliated Hospital of University of South China · NCT06277414
This study is trying to see if using machine learning can help predict complications after ERCP procedures for patients undergoing this treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | The First Affiliated Hospital of University of South China (other) |
| Locations | 1 site (Hengyang, Hunan) |
| Trial ID | NCT06277414 on ClinicalTrials.gov |
What this trial studies
This study aims to develop predictive models for complications that may arise after Endoscopic Retrograde Cholangiopancreatography (ERCP) using machine learning techniques. By collecting data from laboratory tests, imaging results, and patient symptoms, the researchers will analyze this information to identify risk factors and improve patient outcomes. The study is observational, focusing on routine ERCP patients to gather comprehensive data for model development.
Who should consider this trial
Good fit: Ideal candidates for this study are patients scheduled for routine ERCP procedures.
Not a fit: Patients who are unwilling or unable to consent, pregnant or breastfeeding, or currently experiencing acute pancreatitis may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the ability to predict and prevent complications following ERCP, leading to improved patient safety and outcomes.
How similar studies have performed: While predictive modeling in medical settings has shown promise, this specific approach to ERCP complications is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Routine ERCP patients Exclusion Criteria: * Unwillingness or inability to consent for the study * Pregnant women or breastfeeding * current acute pancreatitis
Where this trial is running
Hengyang, Hunan
- The First Affiliated Hospital of University of South China — Hengyang, Hunan, China (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Endoscopic Retrograde Cholangiopancreatography